Matsuoka vs Wolf
Markets
Every market on this event, moneyline first. Select one to compare it across platforms in the side panel.
| Outcome | Best | Volume | Azuro | Gemini | Kalshi | Limitless | Novig | Polymarket | Polymarket US |
|---|---|---|---|---|---|---|---|---|---|
Jeffrey John Wolf Winner | 99.0%Kalshi | $1.1M | — | — | — | — | — | ||
Hayato Matsuoka | 0.9%Polymarket | $1.2M | — | — | — | — | — |
AI-generated summary, may be inaccurate.
This market covers the ATP Challenger Vancouver quarterfinal between Hayato Matsuoka and J.J. Wolf, with both Polymarket and Kalshi offering a winner market. Bettors must choose between Matsuoka advancing or Wolf advancing; there is no draw in tennis, and both platforms resolve to the player who wins the match (or, on Polymarket, 50-50 in the event of a walkover or cancellation before play begins). The market's snapshot, taken on July 31, pegged Wolf as the clear favourite at 69.0% on Kalshi and 68.0% on Polymarket — a near-identical read across platforms with a negligible 1.0-percentage-point spread. Matsuoka was priced at 33.0% on Kalshi and 32.0% on Polymarket. The consensus favoured Wolf by roughly a 2-to-1 margin, consistent with his status as a protected ranking (PR) entrant — a designation typically held by players returning from injury who retain their prior ranking — compared to Matsuoka entering as a lucky loser. However, the official ATP Tour results tell a strikingly different story: Hayato Matsuoka won the match 6-3, 6-2, a dominant straight-sets performance. At snapshot time the markets had not yet reflected this outcome, with both still showing Wolf as the heavy favourite. The result means both Polymarket and Kalshi are poised to resolve fully in Matsuoka's favour, wiping out the ~69% probability the market had assigned to Wolf. The near-zero spread between Polymarket and Kalshi throughout this event confirms that both platforms were pricing the match consistently — and both were caught flat-footed by Matsuoka's convincing upset.
Discussion (0)
Log in to join the discussion.
No comments yet — start the discussion.